The Journal of Pediatrics
Volume 154, Issue 4 , Pages 588-591, April 2009

Vascular Dysfunction in Glycogen Storage Disease Type I

  • Angelina V. Bernier, MD

      Affiliations

    • Division of Pediatric Endocrinology and Glycogen Storage Disease Program, Department of Pediatrics, University of Florida, Gainesville, FL
  • ,
  • Catherine E. Correia, BS

      Affiliations

    • Division of Pediatric Endocrinology and Glycogen Storage Disease Program, Department of Pediatrics, University of Florida, Gainesville, FL
  • ,
  • Michael J. Haller, MD

      Affiliations

    • Division of Pediatric Endocrinology and Glycogen Storage Disease Program, Department of Pediatrics, University of Florida, Gainesville, FL
  • ,
  • Douglas W. Theriaque, MS

      Affiliations

    • General Clinical Research Center, University of Florida, Gainesville, FL
    • Division of Biostatistics, Department of Epidemiology and Health Policy Research, University of Florida, Gainesville, FL
  • ,
  • Jonathan J. Shuster, PhD

      Affiliations

    • General Clinical Research Center, University of Florida, Gainesville, FL
    • Division of Biostatistics, Department of Epidemiology and Health Policy Research, University of Florida, Gainesville, FL
  • ,
  • David A. Weinstein, MD, MMSc

      Affiliations

    • Division of Pediatric Endocrinology and Glycogen Storage Disease Program, Department of Pediatrics, University of Florida, Gainesville, FL
    • Corresponding Author InformationReprint requests: David A. Weinstein, MD, MMSc, Division of Pediatric Endocrinology, University of Florida, PO Box 100296, Gainesville, FL 32610-0296

Received 13 August 2008; received in revised form 2 October 2008; accepted 29 October 2008. published online 22 December 2008.

Objective

To determine cardiovascular disease risk in a larger cohort of patients with glycogen storage disease (GSD) I through the use of noninvasive measures of arterial function and anatomy.

Study design

Carotid intima media thickness (IMT), radial artery tonometry, and brachial artery reactivity were performed in 28 patients with GSD I (13F/15M, mean age 23 years) and 23 control subjects (19F/4M, mean age 23 years).

Results

The primary outcome measure, mean left distal IMT was greater in the GSD cohort (0.500 ± 0.055 mm) than in the control group (0.457 ± 0.039 mm) (P = .002, adjusted for age, sex, and body mass index). Mean augmentation index measured by radial artery tonometry was higher in the GSD cohort (16.4% ± 14.0%) than in the control group (2.4% ± 8.7%) (P < .001). No significant difference was observed between mean brachial artery reactivity in the GSD cohort (6.3% ± 4.9% change) versus control subjects (6.6% ± 5.1% change) (P = .46).

Conclusions

GSD I is associated with arterial dysfunction evident by increased IMT and augmentation index. Patients with GSD I may be at increased risk for cardiovascular disease.

Abbreviations: BAR, Brachial artery reactivity, CVD, Cardiovascular disease, GSD, Glycogen storage disease, HDL, High-density lipoprotein, IMT, Intima media thickness, RAT, Radial artery tonometry, TRAP, Total radical-trapping antioxidant parameter

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Support for this project was provided by the Association for Glycogen Storage Disease, Scott Miller Glycogen Storage Disease Research Fund, the National Center for Research Resources General Clinical Research Center grant M01 RR 00082, National Institutes of Health, and NIH Mentored Career Award K23 RR 017560 (DAW). The authors declare no conflicts of interest.

PII: S0022-3476(08)00957-8

doi:10.1016/j.jpeds.2008.10.048

The Journal of Pediatrics
Volume 154, Issue 4 , Pages 588-591, April 2009